| 000 | 01752 a2200517 4500 | ||
|---|---|---|---|
| 005 | 20250516221835.0 | ||
| 264 | 0 | _c20141111 | |
| 008 | 201411s 0 0 eng d | ||
| 022 | _a1532-1827 | ||
| 024 | 7 |
_a10.1038/bjc.2014.344 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aCohen, S J | |
| 245 | 0 | 0 |
_aPhase I study of capecitabine combined with radioembolization using yttrium-90 resin microspheres (SIR-Spheres) in patients with advanced cancer. _h[electronic resource] |
| 260 |
_bBritish journal of cancer _cJul 2014 |
||
| 300 |
_a265-71 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial, Phase I; Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 | _aAged, 80 and over |
| 650 | 0 | 4 |
_aAntimetabolites, Antineoplastic _xadministration & dosage |
| 650 | 0 | 4 | _aCapecitabine |
| 650 | 0 | 4 | _aCohort Studies |
| 650 | 0 | 4 |
_aDeoxycytidine _xadministration & dosage |
| 650 | 0 | 4 |
_aEmbolization, Therapeutic _xmethods |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aFluorouracil _xadministration & dosage |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMaximum Tolerated Dose |
| 650 | 0 | 4 | _aMicrospheres |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aNeoplasms _xdrug therapy |
| 650 | 0 | 4 | _aProspective Studies |
| 650 | 0 | 4 |
_aYttrium Radioisotopes _xadministration & dosage |
| 700 | 1 | _aKonski, A A | |
| 700 | 1 | _aPutnam, S | |
| 700 | 1 | _aBall, D S | |
| 700 | 1 | _aMeyer, J E | |
| 700 | 1 | _aYu, J Q | |
| 700 | 1 | _aAstsaturov, I | |
| 700 | 1 | _aMarlow, C | |
| 700 | 1 | _aDickens, A | |
| 700 | 1 | _aCade, D N | |
| 700 | 1 | _aMeropol, N J | |
| 773 | 0 |
_tBritish journal of cancer _gvol. 111 _gno. 2 _gp. 265-71 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1038/bjc.2014.344 _zAvailable from publisher's website |
| 999 |
_c23970576 _d23970576 |
||